SCHEMBL263684

SCHEMBL263684

COCCOc1cc(N)c(C(=O)O)cc1OCCOC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 5/20 0.40
KMT2A Q03164 3/20 0.40
PTK2B Q14289 1/20 0.40
IDO1 P14902 1/20 0.40
POLB P06746 2/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGER4 P35408 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
CDC25B P30305 1/20 0.39
CASP6 P55212 1/20 0.39
RCE1 Q9Y256 1/20 0.39
GFER P55789 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29597889 0.95 KDM4E (0.53) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL2330272 0.95 KDM4E (0.53) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL27122666 0.88 HSD17B10 (0.42) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL15966727 0.87 KDM4E (0.45) KDM4EKMT2AIKBKBMEN1MAPT
SCHEMBL5052320 0.87 CYP3A4 (0.46) KDM4ETSHRALDH1A1KMT2APOLB
SCHEMBL1972990 0.87 ALDH1A1 (0.40) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL2235600 0.85 KDM4E (0.56) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL3470108 0.85 KDM4E (0.65) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL18300979 0.84 TSHR (0.49) KDM4ETSHRHSD17B10ALDH1A1KMT2A
SCHEMBL18089590 0.84 KDM4E (0.54) KDM4ETSHRALDH1A1KMT2ALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1650196-B1 PROCESS FOR PRODUCING 6,7-BIS(2-METHOXYETHOXY)-QUINAZOLIN-4-ONE UBE INDUSTRIES (JP) 2011-03-30 EP claimed
US-8367824-B2 Reacting anthranilic acid with formic acid compound in presence of a catalyst and solvent UBE INDUSTRIES LTD. (JP) 2013-02-05 US disclosed
CN-102827086-A Preparation method for 4-chloro-6,7-bis(2-methoxyethoxy)quinazoline UNIV ZHEJIANG SCIENCE & TECH 2012-12-19 CN disclosed
US-8133999-B2 Process for preparation of 6, 7-bis(2-methoxyethoxy) quinazolin-4-one UBE INDUSTRIES, LTD. (JP) 2012-03-13 US disclosed
EP-1650196-B1 PROCESS FOR PRODUCING 6,7-BIS(2-METHOXYETHOXY)-QUINAZOLIN-4-ONE UBE INDUSTRIES (JP) 2011-03-30 EP disclosed
EP-1650196-B1 PROCESS FOR PRODUCING 6,7-BIS(2-METHOXYETHOXY)-QUINAZOLIN-4-ONE UBE INDUSTRIES (JP) 2011-03-30 EP disclosed
US-20090253909-A1 PROCESS FOR PREPARATION OF 6, 7-BIS (2-METHOXYETHOXY) QUINAZOLIN-4-ONE UBE INDUSTRIES, LTD. (JP) 2009-10-08 US disclosed
EP-1477481-B1 PROCESS FOR PRODUCING QUINAZOLIN-4-ONE DERIVATIVE UBE INDUSTRIES (JP) 2009-07-22 EP disclosed
WO-2007138613-A2 A PROCESS FOR SYNTHESIS OF [6,7-BIS-(2-METHOXYETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYLPHENYL)AMINE HYDROCHLORIDE VITTAL MALLYA SCIENTIFIC RESEARCH FOUNDATION (IN) 2007-12-06 WO disclosed
WO-2007138612-A2 A PROCESS FOR SYNTHESIS OF [6,7-BIS-(2-METHOXYETHOXY)-QUINAZOLIN-4- YL]-(3-ETHYNYLPHENYL)AMINE HYDROCHLORIDE VITTAL MALLYA SCIENTIFIC RESEARCH FOUNDATION (IN) 2007-12-06 WO disclosed
EP-1650196-A4 PROCESS FOR PRODUCING 6,7-BIS(2-METHOXYETHOXY)-QUINAZOLIN-4-ONE UBE INDUSTRIES (JP) 2007-02-28 EP disclosed
US-20060276647-A1 Process for producing 6, 7-bis (2-methoxyethoxy)-quinazolin-4-one UBE INDUSTRIES, LTD (JP) 2006-12-07 US disclosed
EP-1650196-A1 PROCESS FOR PRODUCING 6,7-BIS(2-METHOXYETHOXY)-QUINAZOLIN-4-ONE Ube Industries, Ltd. (JP) 2006-04-26 EP disclosed
US-20050080262-A1 Process for producing quinazolin-4-one derivative UBE INDUSTRIES, LTD. (JP) 2005-04-14 US disclosed
WO-2005012264-A1 PROCESS FOR PRODUCING 6,7-BIS(2-METHOXYETHOXY)-QUINAZOLIN-4-ONE UBE INDUSTRIES, LTD. (JP) 2005-02-10 WO disclosed
EP-1477481-A1 PROCESS FOR PRODUCING QUINAZOLIN-4-ONE DERIVATIVE Ube Industries, Ltd. (JP) 2004-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276647-A1 Process for producing 6, 7-bis (2-methoxyethoxy)-quinazolin-4-one CPS1, CYP3A4, RPS27A KDM4E 287/4885TSHR 4725/4885HSD17B10 1866/4885
US-20090253909-A1 PROCESS FOR PREPARATION OF 6, 7-BIS (2-METHOXYETHOXY) QUINAZOLIN-4-ONE CYP4F11, OGFR, CYP4B1 KDM4E 93/4885TSHR 4102/4885HSD17B10 3223/4885
US-20050080262-A1 Process for producing quinazolin-4-one derivative NQO2, SDHA, CYP3A4 KDM4E 879/4885TSHR 2706/4885HSD17B10 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.